Infectious Disease Pharmacology: Precision Strategies for Prescribing download , Infectious Disease Pharmacology: Precision Strategies for Prescribing review , Infectious Disease Pharmacology: Precision Strategies for Prescribing free
Infectious Disease Pharmacology: Precision Strategies for Prescribing
Eric Wombwell, PharmD, BCIDP
Dr. Eric Wombwell is a board-certified infectious diseases pharmacist and clinical associate professor for the Department of Pharmacy Practice and Administration at the University of Missouri – Kansas City, School of Pharmacy. Eric completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP accredited pharmacy practice residency at the Kansas City VA Medical Center. Following residency, he accepted a full-time non-tenured clinical faculty position at the University of Missouri – Kansas City, School of Pharmacy. His teaching responsibilities include infectious diseases topics throughout the curriculum. Eric also has a clinical appointment at Centerpoint Medical Center rounding with the infectious diseases consult team and supporting antimicrobial stewardship efforts at the facility.
Eric is regularly published in pharmacy and infectious diseases research and is frequently invited to deliver continuing education presentations locally and nationally to various health-professional audiences. He is recognized for excellence in teaching through various awards, including the “Missouri Pharmacist Association – UMKC Faculty Member of the Year”, and the “University of Missouri – Kansas City Provost’s Award for Excellence in Teaching”.
Speaker Disclosures:
Financial: Eric Wombwell has an employment relationship with the University of Missouri. He receives a speaking honorarium, recording royalties, and a consulting fee from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Eric Wombwell is a member of the Society of Infectious Diseases Pharmacists, the Missouri Pharmacists Association, American Association of Colleges of Pharmacy, Infectious Diseases Society of America, and Centerpoint Medical Center.
Audrey M. Stevenson, PhD, MPH, MSN, FNP-BC
Audrey M. Stevenson, PhD, MPH, MSN, FNP-BC, is a family nurse practitioner with more than 40 years of clinical and public health, and leadership experience.
Dr. Stevenson, who holds a Master of Public Health and Master of Nursing degrees, received her doctorate in public health from the University of Utah. She has worked in public health for the past 34 years and is the former Division Director of Family Health and Clinical Services of the Salt Lake County Health Department in Salt Lake City, Utah. She is currently working in clinical research and teaching graduate FNP and MPH students at two universities.
A family nurse practitioner, Dr. Stevenson has worked in various inpatient and ambulatory settings and was a previous nurse consultant to the Salt Lake City School District. She is a current faculty member of a graduate Nurse Practitioner program and a Master of Public Health program. She has published several articles and has been a national and international speaker on topics affecting school nurses, advanced practice nurses, and other medical and pharmacy providers. Dr. Stevenson is also a member of the statewide vaccine advisory board, where she collaborates on vaccine polices and recommendations for the state. Previously, Dr. Stevenson served as Vaccination Branch Director for the Covid-19 Incident Command for Salt Lake County.
Speaker Disclosures:
Financial: Audrey Stevenson has employment relationships with the University of Utah and the University of Phoenix. She receives a speaking honorarium from Merck, Sequirus, Sanofi, and GSK. She receives a speaking honorarium and recording royalties PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Audrey Stevenson is a member of the American Nurses Association and the American Association of Nurse Practitioners.
Paul Langlois, APN, PhD, CCRN, CCNS
Paul Langlois, APN, PhD, CCRN, CCNS, is a critical care clinical specialist in the surgical, medical, neurologic, burn, CCU, and trauma ICUs of Cook County Hospital, Chicago. Drawing on over 40 years of experience assessing and managing patients with life-threatening diseases, Dr. Langlois provides advanced-level training to nurses, physician assistants, nurse practitioners, respiratory therapists, and physicians.
Dr. Langlois is committed to providing the highest quality of care to patients through advanced education. His presentations are evidence-based, timely, and provide participants with numerous case studies to facilitate critical thinking. As a bedside clinical nurse specialist, he has developed several institution-wide protocols for the multidisciplinary assessment and management of infectious disease and multi-system organ failure patients.
His presentations are enthusiastically delivered and offer highly practical tips that help make the most challenging concepts easy to understand. Linking knowledge to clinical practice is the goal of every educational program.
Speaker Disclosures:
Financial: Paul Langlois has employment relationships with Cook County Hospital and Emergency Care Consultants. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Paul Langlois is a member of the American Nurses Association and the American Association of Critical Care Nurses.
Christa A. Schorr, DNP, MSN, RN, NEA-BC
Christa A. Schorr, DNP, MSN, RN, NEA-BC, is a clinical nurse scientist at Cooper University Health Care and Professor of Medicine at Cooper Medical School of Rowan University. Dr. Schorr has more than 25 years of clinical, quality improvement, and research experience in critical care. She has authored or co-authored more than 200 peer-reviewed articles, invited book chapters, and abstracts. Dr. Schorr was the group-head for the 2021 surviving Sepsis Campaign Guidelines Long-Term Outcomes and Goals of Care Section. In 2021, she was the recipient of the prestigious Asmund S. Laerdal Memorial Award in conjunction with the 50th Annual Society of Critical Care Medicine Congress – Recognition for research and publications.
Speaker Disclosures:
Financial: Christa Schorr has an employment relationship with Cooper University Hospital. She receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Christa Schorr is a member of the American Association of Critical Care Nurses and the American Association of Critical Care Nurses. She is an editor and manuscript reviewer for several publications, please contact PESI, Inc for a complete list.
Teri Woo, PhD, ARNP, CPNP-PC, CNL, FAANP
Teri Woo, PhD, ARNP, CPNP-PC, CNL, FAANP, is professor and director of nursing at Saint Martin’s University in Lacey, Washington. She completed her BSN, MSN and post Masters PNP certificate at Oregon Health Sciences University, and her PhD in nursing at University of Colorado Denver College of Nursing. Dr. Woo is a Fellow of the American Association of Nurse Practitioners and lead author of Pharmacotherapeutics for Advanced Practice Nurse Prescribers and has written and lectured extensively in the area of nurse practitioner prescribing and pediatric pharmacology. She served on the NAPNAP board from 2017 to 2021 and has served on the Pediatric Nurse Certification Board Pharmacology CE committee since 2002. Dr. Woo practices as a PNP-PC at Mary Bridge Children’s Hospital Urgent Care in Washington.
Speaker Disclosures:
Financial: Dr. Teri Woo has employment relationships with Saint Martin’s University and Woodcreek / Mary Bridge Urgent Care Clinic. She receives compensation as a consultant. Dr. Woo receives grants from the Health Resources and Services Administration. She receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Teri Woo is a member of the American Nurses Association, the American Association of Nurse Practitioners, and the National Association of Pediatric Nurse Practitioners.
Course
Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians
Eric Wombwell, PharmD, BCIDP
Approx. 6 Hours
Watch this training and learn proper prescribing, patient education and monitoring procedures for a variety of drug regimens used to treat common acute and chronic infectious diseases. Choosing an antibacterial agent can be challenging, given the plethora of drugs available on the market and the emerging trend in bacterial resistance.
You will learn the pharmacology of different classes of antimicrobials used to treat infectious disease states encountered in clinical practice. Discover the spectrums of activity, pharmacokinetic characteristics and parameters for monitoring therapeutic outcomes. Emphasis is placed on the new antimicrobials and advances in evidence-based treatment guidelines.
You will finish this training better prepared to design appropriate and cost-effective drug regimens for improved therapeutic outcomes.
Vaccine-Preventable Diseases in the Older Adults
Audrey Stevenson, PhD, MPH, MSN, FNP-BC
2 Hours 02 Minutes
We know that certain diseases disproportionately impact older adults, resulting in higher rates of hospitalizations, complications, and deaths. In this session, we will discuss the most common vaccine-preventable diseases in older adults, including transmission, clinical presentation, diagnosis, treatment, and prevention. We will also discuss the most current vaccine recommendations and therapies to care for the older adult.
Emerging and Current Infectious Diseases in the Critical Care Setting: SARs-CoV/COVID-19, Monkey Pox, Hepatitis, Tuberculosis & Influenza
Paul Langlois, APN, PhD, CCRN, CCNS
1 Hour 59 Minutes
Since the beginning of the 21st century, we have seen novel infectious diseases and infectious diseases not endemic to the US manifest themselves in an explosive way. The daily news programs and the internet are providing sometimes overwhelming information that is often inadequate in scope.
In this session, Paul Langlois, APN, PhD, CCRN, CCNS, will provide the latest guidelines and recommendations from the Centers for Disease Control (CDC) and Infectious Disease Society of America (IDSA) on current infectious diseases affecting our patients: SARS-CoV2/COVID-19; Monkey pox; hepatitis-A, -B and –C; tuberculosis and Influenza. In addition to history and physical assessment findings, Paul will also highlight recognition methods, FDA-approved and investigational medications and, where indicated, vaccines. Case studies will solidify learning objectives.
Sepsis is a life-threatening condition and continues to have a high morbidity and mortality. Developing an understanding of early sepsis recognition, applying the appropriate treatment in a timely manner can help save lives. Nurses are essential in early recognition and early treatment. The most current 2021 Surviving Sepsis Campaign (SSC) Guidelines are useful in providing recommendations and rationale for treatment. Also new to the 2021 guidelines is a section on long-term outcomes and goals of care. As more and more individuals survive sepsis, resources to aid in their recovery are needed to improve long-term outcomes. This talk is relevant for individuals who care for patients with sepsis and septic shock and is a core measure for the Centers of Medicare and Medicaid. Nurses can make a difference in the lives of patients with sepsis and in the process improve compliance with the performance measure as well.
Preventing and Treating Viral Infections in Children
Teri Woo, PhD, ARNP, CPNP-PC, CNL, FAANP
1 Hour 07 Minutes
In this course, we will explore the intracellular life cycle of viral pathogens and review immunizations that prevent or mitigate common viral infections…such as influenza, herpes, varicella, and HepC.
With increasing antimicrobial resistance, our role as judicious prescribers of antibiotics in key. In this session, antibiotic pharmacology, antibiograms, and inappropriate antibiotic prescribing will be discussed. Recommendations for penicillin allergy will also be covered.
Do you know how to prescribe the right drug for the right bug? Selecting the correct antibiotic to prescribe for treatment of respiratory, skin, urinary, and eye infections will be discussed. Antibiotic treatment for gonorrhea and chlamydia is also covered. After this session, you will feel confident to order the right antibiotic every time.
The vaccine recommendations keep changing, with new vaccines and new combinations available. Learn about the latest CDC and ACIP recommendations for vaccines, travel recommendations, and working with families to overcome vaccine hesitancy.
Frequently Asked Questions:
Innovative Business Model:
Embrace the reality of a genuine business! Our approach involves forming a group buy, where we collectively share the costs among members. Using these funds, we purchase sought-after courses from sale pages and make them accessible to individuals facing financial constraints. Despite potential reservations from the authors, our customers appreciate the affordability and accessibility we provide.
The Legal Landscape: Yes and No:
The legality of our operations falls into a gray area. While we lack explicit approval from the course authors for resale, there’s a technicality at play. When procuring the course, the author didn’t specify any restrictions on resale. This legal nuance presents both an opportunity for us and a boon for those seeking budget-friendly access.
Quality Assurance: Unveiling the Real Deal:
Delving into the heart of the matter – quality. Acquiring the course directly from the sale page ensures that all documents and materials are identical to those obtained through conventional means. However, our differentiator lies in going beyond personal study; we take an extra step by reselling. It’s important to note that we are not the official course providers, meaning certain premium services aren’t included in our package:
No coaching calls or scheduled sessions with the author.
No access to the author’s private Facebook group or web portal.
No entry to the author’s exclusive membership forum.
No direct email support from the author or their team.
We operate independently, aiming to bridge the affordability gap without the additional services offered by official course channels. Your understanding of our unique approach is greatly appreciated.
Refund is acceptable:
Firstly, item is not as explained
Secondly, Item do not work the way it should.
Thirdly, and most importantly, support extension can not be used.
Thank you for choosing us! We’re so happy that you feel comfortable enough with us to forward your business here.
Reviews (0)
Reviews
There are no reviews yet.
Be the first to review “Infectious Disease Pharmacology: Precision Strategies for Prescribing” Cancel reply
Reviews
There are no reviews yet.